China Universal Asset Management »

Sage Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $217k 12k 18.74
2023-12-31 $150k 6.9k 21.67
2023-09-30 $32k 1.5k 20.58
2023-06-30 $37k 783 47.02
2023-03-31 $34k 809 41.96
2022-12-31 $23k 605 38.14
2022-09-30 $22k 556 39.57

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Sage Therapeutics

Wellington Management Company
FMR
Vanguard Group
BlackRock
Bellevue Group
Morgan Stanley
Geode Capital Management
Jpmorgan Chase & Co
Deutsche Bank Aktiengesellschaft
Palo Alto Investors
Dimensional Fund Advisors
T. Rowe Price Associates
Point72 Asset Management
Samlyn Capital
Jacobs Levy Equity Management

View all funds holding Sage Therapeutics